Sodium Acetate Injection Shortage: Current Availability and Manufacturer Updates
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA reports an ongoing shortage of Sodium Acetate Injection, used in Total Parenteral Nutrition, though Fresenius Kabi USA currently reports product availability.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Sodium Acetate.
Sodium Acetate Injection Shortage Update
What's in Shortage
Generic Name: Sodium Acetate Injection
Brand Name: SODIUM ACETATE
Dosage Form: Injection
Therapeutic Category: Total Parenteral Nutrition
Current Status: Current Shortage
Initial Posting Date: March 23, 2016
Last Updated: February 5, 2026
Which Manufacturers Are Affected
The following manufacturer is listed in the FDA database regarding this shortage:
- Fresenius Kabi USA, LLC
- Status: Available
- Presentation: Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)
- Notes: The manufacturer advises checking wholesalers for current inventory.
- Contact Information: 888-386-1300
Why There's a Shortage
No specific reason for the shortage was provided in the source data.
What Patients Should Do
If you or a loved one relies on Sodium Acetate Injection as part of Total Parenteral Nutrition, please consider the following steps:
- Consult Your Healthcare Provider: Discuss your treatment plan with your doctor. Do not make any changes to your medical regimen without professional guidance.
- Talk to Your Pharmacist: Pharmacists can provide real-time updates on local stock and may be able to coordinate with wholesalers to secure supply.
- Contact the Manufacturer: For specific questions regarding supply, you may reach Fresenius Kabi USA at 888-386-1300.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider regarding medication changes or alternatives.
Source
Attribution: FDA Drug Shortage Database
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.